sibutramine has been researched along with Complications, Pregnancy in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations." | 7.74 | Exposure to sibutramine during pregnancy. ( Garcia-Bournissen, F; Koren, G; Shrim, A, 2007) |
| "Sibutramine is a drug that is used in the treatment of obesity." | 7.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| "To our knowledge, this is the first report of sibutramine exposure in pregnancy." | 7.72 | Sibutramine use in pregnancy: report of two cases. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations." | 3.74 | Exposure to sibutramine during pregnancy. ( Garcia-Bournissen, F; Koren, G; Shrim, A, 2007) |
| "Sibutramine is a drug that is used in the treatment of obesity." | 3.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| "To our knowledge, this is the first report of sibutramine exposure in pregnancy." | 3.72 | Sibutramine use in pregnancy: report of two cases. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "Weight loss during pregnancy is therefore considered a risk factor." | 1.38 | Appetite suppressants in pregnancy. ( Hubičková Heringová, L; Kralova, T; Manakova, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manakova, E | 1 |
| Kralova, T | 1 |
| Hubičková Heringová, L | 1 |
| Einarson, A | 1 |
| Bonari, L | 1 |
| Sarkar, M | 1 |
| McKenna, K | 1 |
| Koren, G | 2 |
| Kadioglu, M | 1 |
| Ulku, C | 1 |
| Yaris, F | 1 |
| Kesim, M | 1 |
| Kalyoncu, NI | 1 |
| Yaris, E | 1 |
| Ramzi, F | 1 |
| Elias, D | 1 |
| Mona, S | 1 |
| Zreik, TG | 1 |
| De Santis, M | 1 |
| Straface, G | 1 |
| Cavaliere, AF | 1 |
| Carducci, B | 1 |
| Caruso, A | 1 |
| Garcia-Bournissen, F | 1 |
| Shrim, A | 1 |
6 other studies available for sibutramine and Complications, Pregnancy
| Article | Year |
|---|---|
Appetite suppressants in pregnancy.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Appetite Depressants; Cyclobutanes; Czech Republic; | 2012 |
Exposure to sibutramine during pregnancy: a case series.
Topics: Anti-Obesity Agents; Cyclobutanes; Female; Humans; Maternal Exposure; Obesity; Pregnancy; Pregnancy | 2004 |
Sibutramine use in pregnancy: report of two cases.
Topics: Adult; Antidepressive Agents; Cyclobutanes; Female; Follow-Up Studies; Humans; Infant, Newborn; Male | 2004 |
Sibutramine in pregnancy.
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Humans; Infant, Newborn; Male; Obesity; Pregnancy | 2005 |
Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.
Topics: Abnormalities, Drug-Induced; Adult; Appetite Depressants; Body Mass Index; Counseling; Cyclobutanes; | 2006 |
Exposure to sibutramine during pregnancy.
Topics: Antidepressive Agents; Cohort Studies; Cyclobutanes; Female; Humans; Infant, Newborn; Pregnancy; Pre | 2007 |